
Press releases
20th Mar 2023
Genedrive® MT-RNR1 to commence roll out in Greater Manchester
genedrive plc (AIM:GDR), the point of care molecular diagnostics company, announces that the Ge...
9th Feb 2023
Antibiotic Induced Hearing Loss test receives preliminary recommendation by NICE
genedrive plc (AIM:GDR), the point of care molecular diagnostics company, announces that the UK...
21st Nov 2022
genedrive plc (AIM: GDR), the near patient molecular diagnostics company, announces its audited...